文摘
The major mechanism of resistance to aminoglycosides in clinical bacterial isolates is thecovalent modification of these antibiotics by enzymes produced by the bacteria. Aminoglycoside 2' '-Ibphosphotransferase [APH(2' ')-Ib] produces resistance to several clinically important aminoglycosides inboth Gram-positive and Gram-negative bacteria. Nuclear magnetic resonance analysis of the product ofkanamycin A phosphorylation revealed that modification occurs at the 2' '-hydroxyl of the aminoglycoside.APH(2' ')-Ib phosphorylates 4,6-disubstituted aminoglycosides with kcat/Km values of 105-107 M-1 s-1,while 4,5-disubstituted antibiotics are not substrates for the enzyme. Initial velocity studies demonstratethat APH(2' ')-Ib operates by a sequential mechanism. Product and dead-end inhibition patterns indicatethat binding of aminoglycoside antibiotic and ATP occurs in a random manner. These data, together withthe results of solvent isotope and viscosity effect studies, demonstrate that APH(2' ')-Ib follows the randomBi-Bi kinetic mechanism and substrate binding and/or product release could limit the rate of reaction.